5-(Bromomethyl)pyrimidine

Catalog No.: 
ACLPMN364
CAS No.: 
25198-96-3
Molecular Formula: 
C5H5BrN2
Molecular Weight: 
173.01
5-(Bromomethyl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$180.00InquiryInquiry
250mg98%$359.00InquiryInquiry
1g98%$901.00InquiryInquiry
5g98%$2915.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Bromomethyl)pyrimidine
IUPAC Name5-(bromomethyl)pyrimidine
MDL No.MFCD11226512
Molecular FormulaC5H5BrN2
Molecular Weight173.01
SMILESBrCC1=CN=CN=C1
InChI KeyPPPCEAMFCKQRHG-UHFFFAOYSA-N
SynonymPyrimidine, 5-(bromomethyl)- (8CI,9CI);Pyrimidine, 5-(Bromomethyl)-;5-BroMoMethyl-PyriMidine HBr;Pyrimidine, 5-(bromomethyl)- (8CI,9CI) ISO 9001:2015 REACH
CAS No.25198-96-3

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACLPMN364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTMZK674 route compound structure diagram
    ACTMZK67425193-95-7In Stock
  2. Then
  3. ACLPMN364 route product structure diagram
    ACLPMN36425198-96-3
Inquiry

2. ACLPMN364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTMZK674 route compound structure diagram
    ACTMZK67425193-95-7In Stock
  4. Then
  5. ACLPMN364 route product structure diagram
    ACLPMN36425198-96-3
Inquiry

3. ACLPMN364 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLPMN364 route product structure diagram
    ACLPMN36425198-96-3
Inquiry

Comments (0)